Showing 1831-1840 of 2034 results for "".
- Scientists Use Revolutionary Gene-Editing Tool to Edit Inside a Patienthttps://modernod.com/news/in-a-1st-scientists-use-revolutionary-gene-editing-tool-to-edit-inside-a-patient/2477349/For the first time, scientists have used the gene-editing technique CRISPR to try to edit a gene while the DNA is still inside a person’s body, according to an NPR
- Salus University and National Vision Partner to Educate Optometry Students on Remote Eye Exam Technologyhttps://modernod.com/news/salus-university-and-national-vision-partner-to-educate-optometry-students-on-remote-eye-exam-technology/2477343/Salus University has partnered with National Vision to advance optometric education via a pilot program focused on training students on conducting remote eye exams utilizing high-tech equipment and real-time secure HD video conferencing. The technology enables optometrists to see patients remotel
- Orbis International Secures $500,000 Grant for Flying Eye Hospitalhttps://modernod.com/news/orbis-international-secures-500000-grant-for-flying-eye-hospital/2477337/The Conrad N. Hilton Foundation will invest $500,000 to support the sight-saving work Orbis International carries out on its Flying Eye Hospital, the world’s only fully accredited ophthalmic teaching hospital on board an MD-10 aircraft. The one-time gran
- Regeneron: Eylea Reduced Risk of Developing Vision-Threatening Events by 75% After 2 Years in Patients With DRhttps://modernod.com/news/regeneron-eylea-reduced-risk-of-developing-vision-threatening-events-by-75-after-two-years-in-patients-with-dr/2477283/Regeneron Pharmaceuticals announced positive 2-year results from the phase 3 PANORAMA trial evaluating Eylea (aflibercept) injection 2 mg (0.05 mL) in patients with moderately severe to severe nonproliferative diabetic retinopathy (NPDR). The data were presented for the first time at the Angiogen
- Oertli Launches the ViPer Illuminated Scleral Indentor for Retinal Surgeryhttps://modernod.com/news/oertli-launches-the-viper-illuminated-scleral-indentor-for-retinal-surgery/2477251/Oertli Instrumente announced the launch of the ViPer illuminated scleral indentor, an illuminated indentor for retinal surgery. The ViPer facilitates work in the periphery of the posterior eye segment thanks to its ability to indent and illuminate transsclerally at the same time. Simultan
- Mojo Vision Developing Smart Contact Lenshttps://modernod.com/news/mojo-vision-developing-smart-contact-lens/2477237/Mojo Vision announced it is building what it calls the “world’s first true smart contact lens,” called the Mojo Lens. Mojo Lens is a contact lens with a built-in display that gives people useful and timely information without forcing them to look down at a screen or losing focus on th
- Analysis: FDA’s Efforts to Speed Drug Approval May Have Led to Less Rigorous Clinical Outcome Requirementshttps://modernod.com/news/analysis-fdas-efforts-to-speed-drug-approval-may-have-led-to-less-rigorous-clinical-outcome-requirements/2477231/An analysis published in JAMA suggests that efforts by the FDA to speed the development and approval of drugs may have led to a reduction in the amount of evidence available at the time of authorization by the agency and an increase in more surrogate measures. However, the authors noted
- Novartis Receives Permanent J-code for Beovuhttps://modernod.com/news/novartis-receives-permanent-j-code-for-beovu/2477192/Novartis announced that it has received a permanent J-code for Beovu (brolucizumab-dbll) injection, effective January 1, 2020. With the permanent J-code, retina specialists may now receive more timely reimbursement for Beovu injections, facilitating access for appropriate patients to this
- Ultraviolet Light Exposure Identified as Factor Linked to Eye Disease Fuchs Endothelial Corneal Dystrophyhttps://modernod.com/news/ultraviolet-light-exposure-identified-as-factor-linked-to-eye-disease-fuchs-endothelial-corneal-dystrophy/2477181/A discovery by Mass. Eye and Ear clinician-scientists provides new clues that may help better prevent and treat a genetic eye disease that causes vision loss called Fuchs Endothelial Corneal Dystrophy (FECD). Researchers for the first time have experimentally shown a mechanism that represe
- Trump Administration Advances Plan to Allow Certain Prescription Drug Imports From Canadahttps://modernod.com/news/trump-administration-advances-plan-to-allow-certain-prescription-drug-imports-from-canada/2477183/The US Department of Health and Human Services (HHS) said the Trump administration is pushing ahead with a plan to allow certain prescription drugs to be imported from Canada. “For the first time in history HHS and FDA are open to importation as a means for lower prices,” co